U2Bio

Participation in KIMES 2024

Launching U2Biome Bebe in Amazon

New Listing on KOSDAQ

Participation in KIMES BUSAN 2023

MOU with 'Freshour' for Analyzing Pet's Microbiome

Participation in K-HOSPITAL FAIR 2023

Launching 'U2Biome Bebe'

MOU with 'DAESANG Wellife' for Microbiome Healthcare Platform

MOU with 'CARIVA Thailand Ltd.'

Participation in KIMES 2023

Launching the Application of "U2Biome"

Corporation of Ki Beom Han Hope Sharing, winning the award from the Chairman of the Health and Welfare Committee in the National Assembly

Donation to the Hope Ondol for passing warm winter in 2023

Winning the commendation for contributing Songpa-gu resident in 2022

Participation in the 2022 Seoul X IBK Industrial Bank of Korea's Job Fair

Selection as Seoul-type Small Giants in 2022

Agreement for establishing Smart Health Management System (D-Care Center)

Approval of U2Plex™Q COVID-19 Fast Real-time PCR Kit by the Ministry of Food and Drug Safety

Strategic alliance for the examination solution business for hospitals and clinics (WISEAI Co., Ltd.)

Move of U2Bio head office - 4th floor, 489 Ogeum-ro, Songpa-gu, Seoul

New establishment and reorganization of the BT Research Institute - In Vitro Diagnostics Development Team, Genome Research Team

Commercialization of U2Plex™ Alpha-Thalassemia Diagnostic Kit

Solo entry at KIMES 2022

Winning the award in the management innovation category of 'Korea Creative Management 2022' hosted by the Joong Ang Daily

Move of U2Bio head office - 5th floor, 61, Geoma-ro, Songpa-gu, Seoul

Signing a business agreement for Future Convergence IT Humanities Research Cooperation with Jeju National University

Opening ‘Bye Corona’, a corona test result information application (Songpa-gu)

Approval of U2Plex™ Alpha-Thalassemia Diagnostic Kit by the Ministry of Food and Drug Safety and its registration of patent Insurance registration for Health Insurance Review and Assessment Service

Change in the largest shareholder - NDS Co., Ltd.

Blockchain DID concentrated business (KISA)

Opening Medipium, U2Mobile SMART Application Service specializing in examinations

Acquisition of GMP certification for self-production of in vitro diagnostic medical devices

Launching U2Biome solution

Opening of IT reagent distribution business

Launching the business unit system - Base Business unit, Strategy Business Unit

Launching the business unit system - Base Business unit, Strategy Business Unit

Launching NGS-based gut microbiome analysis service

Launching non-face-to-face integrated information system for COVID-19 screening clinics

Acquisition of In vitro diagnostic medical device manufacturing facility recognition

Selection as a cloud flagship project support project hosted by NIPA

Conclusion of MOU between Korea Clinical Laboratory and U2Bio

Selection as a My Data verification service project hosted by the Korea Data Agency

Conclusion of MOU between Jaincom and U2Bio

Winning the corona test order for the Songpa-gu Public Health Center Its the actual title

Manufacturing approval of U2Plex™ Alpha-Thalassemia Diagnostic Kit (Applying the medical insurance fee for the first time in Korea)

Establishment of NGS Lab in BT Research Institute

Launching Smart QC

Participation in Korea – Thailand 4th Industrial Revolution Showcase

10th Anniversary of U2Bio

Signing the contract with Vichaivej International Hospital in Thailand for HealthWallet and Queue Management System

Determination of thalassemia test kit brand: U2Plex® Alpha-thalassemia Screening PCR Kit

Expansion of online distribution channels: Cooperative Association of OBGYN, etc.

Acquisition of U2Cloud billing software examination certification (Health Insurance Review and Assessment Service)

Held the 10th regular general shareholders' meeting of U2Bio (March 27, 2018)

Winning the contract of Blockchain-based Smart Hospital service development pilot project for Seoul Medical Center (hosted by KISA)

Launching U2LIS solution for examination information management

Determination of telomere test service brand: U2tellolife

U2Plex™ Alpha-Thalassemia Diagnostic Kit patent application (10-2018-0169648)

Investment attraction from Nongshim NDS

Launching customized HealthWallet service and telomere report function for hospitals and clinics

Launching ‘Smart e-Health Questionnaires’ for tablets that can be linked with U2Check

Move of U2Bio headquarters: 65 Geoma-ro, Songpa-gu, Seoul (Macheon-dong)

Held 9th Annual General Shareholders' Meeting of U2Bio (March 30, 2018)

Held a DEMO DAY for IT Research Center

Selection of U2Bio as a leading venture company by the Korea Venture Business Association

Launching Contract Research Organization(CRO) business

Selection as the ‘Supporting Project for Entry of Healthcare to Overseas Market’ by Korea Health Industry Development Institute

Winning the award of the ‘Minister of Trade, Industry and Energy in Creative Economy Venture Startup Festival

Completion of an application for and registration of a patent model related to breastfeeding analysis data utilization and service provision
→ 「Method and Apparatus for Providing Breastfeeding Analysis Services」 (10-2014-0120081)

Completion of an application for and registration of biometric information data analysis technology patent model
→ 「Method and System for Providing Health Care Service Using Biometric Information」 (10-2013-008989)

New Listing on KONEX

Completion of the development of the PHR mobile application service, 「Health Wallet」 and launching the market

Expansion and move of IT Research Institute of U2Bio

Selection of U2Bio as a leading venture company by the Korea Venture Business Association

Move of U2Bio headquarters - B1F (Macheon-dong), 68 Geoma-ro, Songpa-gu, Seoul

Selection of U2Bio as a leading venture company by the Korea Venture Business Association

Launching Moa-moa Service, the cornerstone of life cycle health management service

examination center specialized IT solution based on RFID technology and patient needs Completion of 「SmartCheck」 development and market launching

IT solution for interworking with equipment inside the hospital and automation management service Completion of 「U2Gateway」 development and market launching

Finalization of the ‘Entry of Hospital Service Project to Overseas Market’ conducted by the Ministry of Health and Welfare and selection as the best case

Selection of U2Bio as a leading venture company by the Korea Venture Business Association

Selection as an operator for ‘Entry of hospital service to Overseas Market’ by the Ministry of Health and Welfare for the first time as a venture company

Development and approval of reagent for gene amplification device, Q3ube™ STD8 Real-time PCR kit by the Ministry of Food and Drug Safety

Accreditation of U2Bio's laboratory in Thailand by the Thai government Acquisition of Laboratory Accreditation (LA) for the first time in Korea

Completion of an application for and registration of a patent model to provide progressive paramedic service → 「System and method for providing paramedic service」 (10-2012-0075617) Internalization of U2 Biopath (U2 Pathology Clinic) → Securing the f

Internalization of U2 Biopath (U2 Pathology Clinic)
→ Securing the full spectrum of Histo-Pathological Examination

U2Bio's attraction of Korea-Israel Fund – Recognition and attraction of foreign funds for the first time as a Korean Bio Venture Company

IT service linked with online-based inspection and examination result Launching U2Check – the cornerstone of inspection PHR

Establishment of a corporate-affiliated research institute (BT and IT Business Unit) – Acquisition of government-certified specialized research institute qualification

Partnership contract with 5 hospitals in Thailand and linkage with 30 hospitals in the sector of examination & medical service

Establishment of U2Bio Thailand – HUB for entry and expansion to the Asian market

Exceeding 1,000 Hospitals and clinics customers (Exceeding 2,000 customers in number of customers as of December 2013)

Certification as a venture business by Korea Technology Finance Corporation

Opening of U2Bio Homepage

Move of U2Bio headquarters - 2F, 275, Hwarang-ro, Seongbuk-gu, Seoul (Jangwi-dong)

Partnership with the SLI Laboratory Medicine Clinic
→ Conversion opening to U2 Laboratory Medicine Clinic (securing full spectrum of the clinical test)

Launching Lab2Gene service, an IT service linked with online-based real-time EMR, for the first time in the industry

Establishment of a network of 16 agencies nationwide

Establishment of U2Bio and opening of a molecular diagnostic test (genetic test)